Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS w1x.
Three-part question
In patients with distal esophageal carcinoma undergoing surgical resection, is a transthoracic esophagectomy (TTE) or transhiatal esophagectomy (THE) approach superior?
Clinical scenario
You are at a preoperative assessment clinic seeing a patient who is about to undergo an esophagectomy for a locally advanced distal esophageal cancer. The patient asks you what the difference is between the transhiatal and transthoracic approach, both of which are offered by surgeons in your unit. You resolve to check the literature yourself to see if there are any differences in clinical outcomes between the two approaches.
Search strategy
Medline 1950 to May 2010 using OVID interface wTranshiatal.mpx AND wTransthoracic.mp or En Bloc.mpx AND wesophagectomy.mp. or exp Esophageal Neoplasmsyor exp Esophagectomyyor exp Esophagusyx *Corresponding author. Tel.yfax: q44 2392 286000. E-mail address: omarkhan@iname.com (O.A. Khan).
Search outcome
Two hundred and sixteen papers were found using the reported search. From these, six papers were identified, of which one was a meta-analysis and the rest randomised control trials. These selected papers provided the best evidence to answer the question. These are presented in Table 1 .
Results
Over the last two decades, there has been considerable debate as to the optimum surgical strategy for the resection of distal esophageal tumours. Some authors have advocated a TTE arguing that from an oncological perspective only a combined abdominal and thoracic approach allows adequate lymphadenectomy and loco-regional clearance. Others advocate an abdomino-cervical or THE arguing that the additional lymphadenectomy associated with a transthoracic approach is of no prognostic benefit and is outweighed by the considerable morbidity associated with thoracotomy. In terms of randomised controlled trials, the first was conducted in 1993 by Goldminc et al. who examined 67 patients with squamous cell carcinoma of the esophagus and concluded that the pulmonary complications and inhospital mortality rates between the TTE and THE did not reach a statistically significant difference w2x. In another randomised control trial involving 39 patients with squamous cell carcinoma of the esophagus randomised to underDownloaded from https://academic.oup.com/icvts/article-abstract/12/2/265/742786 by guest on 01 January 2019 go TTE or THE, there was no difference in in-hospital mortality, pulmonary complications and long-term survival between the two approaches w3x. Similarly, Jacobi et al. w4x reported no difference in pulmonary complications or 30-day mortality between THE and TTE.
Unfortunately all three of these randomised control trials were too underpowered to show any statistically significant difference between THE and TTE, particularly with regard to long-term survival. This led Hulscher et al. w5x to conduct a meta-analysis which incorporated the above three randomised control trials as well as many of the other comparative and non-comparative observational studies from 1990 to 1999 in order to increase the number of patients under analysis to a total of 7527. This meta-analysis showed that THE was favourable in terms of pulmonary complications, chyle leakage and wound infections. By contrast, TTE was favourable in terms of cardiac complications, vocal cord paralysis and anastomotic leakage. Overall, THE was associated with a shorter intensive care unit and total inhospital stay as well as of a lower in-patient hospital mortality rate. In terms of long-term survival rates, the three-year and five-year survival rates were not significantly different between THE and TTE, a pattern which was also seen when the randomised control trials underwent meta-analysis in isolation w5x.
Hulscher et al. w6x then went on to conduct the largest randomised control trial with 220 patients with adenocarcinoma of the mid to distal esophagus or the gastric cardia, who either underwent THE or TTE with en-bloc lymphadenectomy. Their study showed that THE was associated with significantly fewer pulmonary complications as well as less chylous leakage, a shorter duration of mechanical ventilation, and shorter stays in the intensive care unit and in the hospital. There was no statistically significant difference between THE and TTE in terms of in-hospital mortality as well as long-term survival after median follow-up of 4.7 years. The same cohort of 220 patients were then followed up over a longer period of time by Omloo et al. w7x in order to compare actual (as opposed to actuarial) five-year survival rates. Unfortunately the longer than expected survival of patients in both the THE and TTE groups meant that this study was unexpectedly underpowered. Nonetheless, this study showed that there was no overall difference with either approach, although there was an ongoing trend for better survival with TTE. Moreover, in a sub-group analysis of patients with between one and eight metastatic lymph nodes, the TTE group did have a significantly improved five-year survival rate as compared with the THE group. This finding is consistent with those of Rizk et al. w8x , whose retrospective analysis of 4627 patients from a worldwide esophageal cancer registry showed extensive lymphadenectomy was associated with improved fiveyear survival rates in patients with limited nodal disease as opposed to those with either early disease or extensive lymphatic involvement. It has therefore been suggested that the transthoracic approach improves the outcome of patients with a limited number of positive lymph nodes because the more extensive lymph node dissection allowed better local clearance; whilst for patients with advanced nodal disease, the poor prognosis of the disease meant that additional loco-regional clearance offered by TTE had no prognostic benefit w8x.
Clinical bottom line
In terms of perioperative outcomes, THE and TTE are associated with different complication rates -specifically THE is associated with significantly less pulmonary complications as well as fewer wound infections, chylous leakage but a higher rate of cardiac complications, vocal cord paralysis and anastomotic leakage as compared with TTE. Overall, THE is associated with a reduced perioperative morbidity as evidenced by with a shorter hospital stay and decreased in-hospital mortality rates. With regard to longterm outcomes, although there is no evidence that TTE or THE result in different overall long-term survival rates, TTE may offer superior five-year survival rates in a sub-group of patients with a limited number of positive lymph nodes.
